|
Volumn 95, Issue 421, 1999, Pages 85-88
|
Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIOBESITY AGENT;
CEFUROXIME;
CEFUROXIME AXETIL;
CEPHALOSPORIN DERIVATIVE;
DEXFENFLURAMINE;
DRUG DERIVATIVE;
FENFLURAMINE;
PRODRUG;
SEROTONIN AGONIST;
ADULT;
ANTIBIOTIC PROPHYLAXIS;
AORTA VALVE REGURGITATION;
ARTICLE;
BACTERIAL ENDOCARDITIS;
CHEMICALLY INDUCED DISORDER;
CHILD;
DENTAL CARE;
HEART DISEASE;
HUMAN;
MITRAL VALVE REGURGITATION;
PRACTICE GUIDELINE;
PRESCHOOL CHILD;
PRESCRIPTION;
RISK FACTOR;
VALVULAR HEART DISEASE;
ADULT;
ANTI-OBESITY AGENTS;
ANTIBIOTIC PROPHYLAXIS;
AORTIC VALVE INSUFFICIENCY;
CEFUROXIME;
CEPHALOSPORINS;
CHILD;
CHILD, PRESCHOOL;
DENTAL CARE;
DEXFENFLURAMINE;
ENDOCARDITIS, BACTERIAL;
FENFLURAMINE;
HEART DISEASES;
HEART VALVE DISEASES;
HUMANS;
MITRAL VALVE INSUFFICIENCY;
PRESCRIPTIONS, DRUG;
PRODRUGS;
RISK FACTORS;
SEROTONIN AGONISTS;
|
EID: 0033193901
PISSN: 00288047
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|